(Date:11/24/2009)...HAI,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsInc...allowedthepatentapplicationfor,itsnano-particleora...ighlyefficientapproachtoincorporatepeptidesor,prot...veryofdrugs,otherwiseadministeredasinjections.NODt...anymacromoleculardrugssuchasinsulin,interferon,gr...
(Date:11/24/2009)...HAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannoun...A)hasapprovedthe,investigationalnewdrugapplication...einsulinformulationtotreatdiabetes.ThisIND,approva...y. , Diabetesisadisordercharacteristicofhighb...abetesoftenresultinseveremicro-and,macro-vasculard...
(Date:11/24/2009)... The FBI recently approved the Promega...rticipating in or generating DNA records for the N... Madison, WI USA (PRWEB) -- The FBI recently app...r use by laboratories participating in, or generat... (NDIS). NDIS currently contains more than seven m...
(Date:11/24/2009)...NTURE:HTL , TORONTO,Nov.24/PRNewswire-FirstCa...apitalInc.,aleadingproviderofadvancedlasersystemsa...nicmarkets,todayreportedoperationalandfinancialres...32009Highlights,-Revenuewas$1.46millioncomparedwi...rcentcomparedwith66.1percentinQ3,2008,-Netlossredu...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7...s Inc. (BCI), a,biopharmaceutical company utilizin...compounds that promote the growth of new neurons f...iseases, announced today that it raised an,additio...nancing, bringing,the total to $50 million. New in... current investors and Alexandria Real Estate Equi...
...s Inc. (BCI), a,biopharmaceutical company utilizin...compounds that promote the growth of new neurons f...iseases, announced today that it raised an,additio...nancing, bringing,the total to $50 million. New in... current investors and Alexandria Real Estate Equi...
...nthera Pharmaceuticals,Inc., a privately held biop... drugs, announced today that Anthera scientists an...ladib (A-002) clinical and,pre-clinical programs a...iology (ATVB) Annual Conference in Atlanta, Georgi... Phase II trials in Varespladib for the,treatment ...
Other Biology Technology:REVISED: BrainCells Inc. Expands Series B Financing to $50 Million 2BrainCells Inc. Expands Series B Financing to $50 Million 2Anthera Presents Data on Varespladib at ATVB Meeting 25x MONO-GOAT POLY C'GATE DILUENT from AbD Serotec
ANTIGEN-DOWN ASSAY DILUENT from AbD Serotec
Rabbit Anti-HALOPERIDOL Polyclonal Antibody, Unconjugated from AbD Serotec
TMB PLUS DILUENT from AbD Serotec
Biology Products: